Formulation: A 100 μg solution in 1:1 acetonitrile/water

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₄)

Schedule: I

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₁₀)

Schedule: I

Formulation: A 100 µg/ml solution in acetonitrile:water (1:1)

Purity: ≥99% deuterated forms (d₁-d₁₀)

Formulation: A crystalline solid

Purity: ≥99% (deuterated forms d₁-d₃)

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₆)

Schedule: I

• 4-hydroxy-N,N-Dimethyltryptamine-d₆
• 4-hydroxy DMT-d₆

Formulation: A 100 μg/ml solution in acetonitrile

• ω-N-methyl-4-Hydroxytryptamine-d₄
• 4-hydroxy-N-Methyltryptamine-d₄
• 4-hydroxy NMT-d₄

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₄)

• N-desmethyl Psilocybin-d₄

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₁₀)

Schedule: I

• 4-hydroxy DMT-d₁₀
• 4-hydroxy-N,N-Dimethyltryptamine-d₁₀

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₆)

Schedule: I

Formulation: A 100 μg/ml solution in acetonitrile

• 4-hydroxy-N,N-Dimethyltryptamine-d₁₀
• 4-hydroxy DMT-d₁₀

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₄)

• ω-N-methyl-4-Hydroxytryptamine-d₄
• 4-hydroxy-N-Methyltryptamine-d₄
• 4-hydroxy NMT-d₄